Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links
OBESITY AND HEART DISEASE RISK
 

Bigger the waist, higher the heart risk

Obese people are in the high risk category for heart diseases and ailments.


BY OUR PHARMA CORRESPONDENT

23 September,2005: Waist circumference is a very important measure for cardiovascular risk. Measuring waist circumference is an easy, low cost indicator that should be added to measurements of other cardiovascular risk factors such as blood pressure, lipid levels and blood glucose, says Professor Sidney Smith, of the Geneva-based World Heart Federation (WHF).

However patients, and even some doctors, are unaware that abdominal fat and waist circumference are important risk factors for heart disease which kills 17 million people worldwide each year. An international survey shows that only a minority of patients and about 60 percent of doctors know that a bigger waist size raises their odds of having a heart attack.

A waist size of 88 centimetres (35 inches) for women and 102 centimetres (40 inches) for men in North America puts them in the high risk category for heart disease.

The figures are slightly lower for people living in Central and Latin America, the Middle East, India and Asia at 80 cm for women and 90 for men. In Japan the high risk category is 90 cm for men and 85 for men and 80 cm for women and 94 for men in the rest of the world. 

Waist measures differ to take into account physique and lifestyle differences around the world. About 11,077 people in 27 countries were questioned in the poll to assess their knowledge about cardiovascular disease, one of the biggest killers in the industrialised world. 

The findings show the need for more education to increase awareness. People know that being overweight or obese increase the odds of heart disease and stroke but where the fat is deposited is important.
Being overweight or obese is calculated by using body mass index (BMI) -- dividing weight in kilograms by height in metres squared. A BMI of more than 25 is overweight. Above 30 is considered obese.

But weight around the middle, or abdominal obesity, has been shown to be a more accurate indicator because it is also linked to other risk factors for heart disease including high cholesterol, type 2 diabetes and raised blood pressure. 

More than half of the patients at risk of heart disease said they have never been informed by their doctors about the link between abdominal fat and raised heart disease risk.

About one in eight men and one in 17 women will die from cardiovascular disease before the age of 65, according to European cardiovascular disease statistics.

BY OUR PHARMA CORRESPONDENT

 

   Pharma Home
LATEST UPDATES

Chinese herbal products could be dangerous: UK 

Knock, knock! It's bird flu at the door

Spider anti-venom to be stocked in UAE hospital 

US may ban animal protein in cattle feed to safeguard against mad cow 

Dr Reddy's nizatidine generic gets FDA nod

Late-onset Pompe disease drug goes on trial

First biologic to treat ulcerative colitis gets US FDA okay

Diverticulitis orally dissolving pill from KV Pharma's  hits the market

Impax delisted from Nasdaq

US FDA okays Lupin's cephalexin

Hepatitis C combo therapy to get priority review in Japan

Lung cancer vaccine trials promising: Introgen

Sugar-free pill Actiq for cancer pain

39 drug firms sued over price rigging in California

Anti fungal terbinafine launched in Europe: Actavis

HIV entry blocking drug data encouraging: Progenics

Allegra generic to be launched in US

Long-acting pain drug data positive: Pain Therapeutics

New kidney cancer drug seeks EU nod

Inhaled insulin may get US FDA clearance

A vaccine against fungus is on way

Enzyme stops progression of HIV in survivors, confirms study

Aclasta found faster-acting in Paget's disease treatment

Beta blocker can start therapy in heart failure: Merck

Halobetasol generic launched in US

Anemia drug darbepoetin's late-stage studies begin: Amgen

Cholesterol generic gets marketing nod in US: Par

Aricept for severe Alzheimer’s disease too: Eisai

Bone regeneration trials begin in US:Mesoblast

New dye to detect early Alzheimer's

Breast forming gene discovered

Thyroid drug to be supplied by IVAX in US

Rituxan, cancer drug can treat rheumatoid arthritis

Yasminelle, low-dose oral contraceptive approved in the Netherlands

Fluarix, anti-flu shot by Glaxo approved

Increlex, drug to treat `abnormally short’ kids approved in US

Anti-HIV drugs prices cut: Gilead

US FDA approves Takeda’s drug combo for type 2 diabetes

Novartis’ drug for breast cancer recurrence to be given priority review in US

US puts off decision on contraceptive pill again

Shire’s ADHD drug Adderall back on list in Canada

WHO calls for emergency action to halt TB in Africa

Some of the Vioxx suits may be settled: Merck

Nasdaq delists Able on bankruptcy filing

Hospira ships ceftriaxone generics to US

Renovis stops sciatica drug studies

 

Home Politics Religion Media Biz Society Tech Travel Books Intl. Autos Automobiles
                        Aviation   Pharma   About Us   Feedback   Links

Latest updates    Contact Us - Feedback    About Us